You can now submit an abstract as of Monday, February 22, 2021. Deadline to submit is Monday, May 17. If you have any questions, please email Brenda Shelton at firstname.lastname@example.org.
About the Conference
This inaugural conference, Stem Cell and Gene Therapy for Neurodevelopmental Disorders, is an early discussion of the development of safe and effective treatments for children suffering from genetic diseases. New advances in this field are actively studied by the expert speakers for this conference, who are all working on cutting-edge research that has the goal of providing future treatments.
The conference is strongly focused on evidence-based science. In bringing these novel cell and gene therapy trials from bench to bedside and into clinical practice, many scientists, physicians, healthcare, regulatory, manufacturing and other staff members must work together in large teams. Our goal is to enhance collaborative research in the fields of Cell and Gene Therapy for Neurodevelopmental disorders.
Targeted Audience: Scientists, Researchers, Clinical Researchers, Post-doctoral Scholars, and Graduate Students
When: September 24-25, 2021
Location: UC Davis MIND Institute Auditorium, Sacramento, CA 95817